By Christian Macher, Country President
Novartis making history in blood cancer for decades
Novartis announces fourth quarter and full year financial results for 2019 at 07:00 CET on January 29, 2020.
Novartis focuses its business on three leading divisions on a global scale: pharmaceuticals, eye care and generics.
